BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8427946)

  • 1. A method for calculating the mean absorption time of drugs undergoing reversible and first-pass metabolism.
    Cheng H; Shum L
    Biopharm Drug Dispos; 1993 Jan; 14(1):71-9. PubMed ID: 8427946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ratio of first to zeroth moments of the plasma profile of an oral drug undergoing first-pass and linear reversible metabolism.
    Cheng H
    Biopharm Drug Dispos; 1995 Dec; 16(9):791-6. PubMed ID: 8580402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mean residence time of oral drugs undergoing first-pass and linear reversible metabolism.
    Cheng H; Jusko WJ
    Pharm Res; 1993 Jan; 10(1):8-13. PubMed ID: 8430064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The area function method for assessing the drug absorption rate in linear systems with zero-order input.
    Cheng H; Jusko WJ
    Pharm Res; 1989 Feb; 6(2):133-9. PubMed ID: 2762213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A general model of metabolite kinetics following intravenous and oral administration of the parent drug.
    Weiss M
    Biopharm Drug Dispos; 1988; 9(2):159-76. PubMed ID: 3370305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico drug absorption tract: An agent-based biomimetic model for human oral drug absorption.
    Deng J; Jhandey A; Zhu X; Yang Z; Yik KFP; Zuo Z; Lam TN
    PLoS One; 2018; 13(8):e0203361. PubMed ID: 30169515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between drug input and mean residence time in the body.
    Bialer M; Look ZM; Silber BM; Yacobi A
    Biopharm Drug Dispos; 1986; 7(6):577-83. PubMed ID: 3828487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of metabolites in bioequivalency assessment. II. Drugs with linear pharmacokinetics and first-pass effect.
    Chen ML; Jackson AJ
    Pharm Res; 1995 May; 12(5):700-8. PubMed ID: 7479556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models.
    Sjögren E; Thörn H; Tannergren C
    Mol Pharm; 2016 Jun; 13(6):1763-78. PubMed ID: 26926043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mean residence time of drugs administered non-instantaneously and undergoing linear tissue distribution and reversible metabolism and linear or non-linear elimination from the central compartment.
    Cheng H
    Biopharm Drug Dispos; 1995 May; 16(4):259-67. PubMed ID: 7548775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro-in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications.
    Cho HJ; Kim JE; Kim DD; Yoon IS
    Drug Dev Ind Pharm; 2014 Aug; 40(8):989-98. PubMed ID: 23981203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Segmental intestinal transporters and metabolic enzymes on intestinal drug absorption.
    Tam D; Tirona RG; Pang KS
    Drug Metab Dispos; 2003 Apr; 31(4):373-83. PubMed ID: 12642462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting human drug pharmacokinetics from in vitro permeability using an absorption-disposition model.
    Fliszar KA; Hill BT; Foster N
    J Pharm Sci; 2007 Aug; 96(8):2161-70. PubMed ID: 17387695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An area function method for calculating the apparent elimination rate constant of a metabolite.
    Cheng HY; Jusko WJ
    J Pharmacokinet Biopharm; 1989 Feb; 17(1):125-30. PubMed ID: 2715930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of first-pass metabolism on metabolite mean residence time determination after oral administration of parent drug.
    Chan KK; Gibaldi M
    Pharm Res; 1990 Jan; 7(1):59-63. PubMed ID: 2300537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug metabolite concentration-time profiles: influence of route of drug administration.
    Houston JB; Taylor G
    Br J Clin Pharmacol; 1984 Apr; 17(4):385-94. PubMed ID: 6721984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mean residence times and distribution volumes for drugs undergoing linear reversible metabolism and tissue distribution and linear or nonlinear elimination from the central compartments.
    Cheng HY; Jusko WJ
    Pharm Res; 1991 Apr; 8(4):508-11. PubMed ID: 1871048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the deconvolution principle in the estimation of absorption and pre-systemic intestinal elimination of drugs.
    Pithavala YK; Soria I; Zimmerman CL
    Drug Metab Dispos; 1997 Nov; 25(11):1260-5. PubMed ID: 9351902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An initial slope method for model structure: independent estimation of the elimination rate constant of a metabolite.
    Piotrovskii VK
    J Pharmacokinet Biopharm; 1991 Jun; 19(3):311-8. PubMed ID: 1875284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.